Literature DB >> 3898275

Modification of diverse experimental immunosuppressive states by glucan.

N R Di Luzio, D L Williams, E R Sherwood, I W Browder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3898275     DOI： 10.1007/bf02918811

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN： 0252-9564


× No keyword cloud information.
  20 in total

1.  INHIBITION OF HOMOGRAFT ACCEPTANCE AND HOMO- AND HETERO-GRAFT REJECTION IN CHIMERAS BY RETICULOENDOTHELIAL SYSTEM STIMULATION.

Authors:  W R WOOLES; N R DILUZIO
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  Identification of a reticuloendothelial stimulating agent in zymosan.

Authors:  S J RIGGI; N R DI LUZIO
Journal:  Am J Physiol       Date:  1961-02

3.  Bacterial infection and the asplenic host: a review.

Authors:  J D Dickerman
Journal:  J Trauma       Date:  1976-08

4.  Effect of Bacillus Calmette-Guérin on immunosuppression from cyclophosphamide, methotrexate, and 5-fluorouracil.

Authors:  F C Sparks; N E Albert; P A Andreone; J H Breeding
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

5.  Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.

Authors:  N R Di Luzio; R McNamee; W I Browder; D Williams
Journal:  Cancer Treat Rep       Date:  1978-11

6.  Suppression of reticuloendothelial function in the rat with cyclophosphamide.

Authors:  R J Sharbaugh; J B Grogan
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

7.  Macrophage-mediated destruction of human malignant cells in vivo.

Authors:  P W Mansell; H Ichinose; R J Reed; E T Krementz; R McNamee; N R Di Luzio
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

8.  Glucan-induced modification of murine viral hepatitis.

Authors:  D L Williams; N R Di Luzio
Journal:  Science       Date:  1980-04-04       Impact factor: 47.728

9.  Glucan-induced enhancement of host resistance to selected infectious diseases.

Authors:  J A Reynolds; M D Kastello; D G Harrington; C L Crabbs; C J Peters; J V Jemski; G H Scott; N R Di Luzio
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

10.  Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan.

Authors:  D L Williams; I W Browder; N R Di Luzio
Journal:  Surgery       Date:  1983-03       Impact factor: 3.982
View more
  6 in total

1.  Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.

Authors:  H A Harima; N F Mendes; E M Mamizuka; M Mariano
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.

Authors:  J Franĕk; J Malina; H Krátká
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

3.  The effect of soluble glucan derivates on spleen colony-forming units in sublethally irradiated mice.

Authors:  A Lísková; J Wagnerová; L Cervenáková; A Kristofová; M Ferencík
Journal:  Folia Microbiol (Praha)       Date:  1990       Impact factor: 2.099

4.  Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.

Authors:  J Malina; J Hofmann; J Franĕk
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

5.  The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism.

Authors:  Benjamin A Fensterheim; Jamey D Young; Liming Luan; Ruby R Kleinbard; Cody L Stothers; Naeem K Patil; Allison G McAtee-Pereira; Yin Guo; Irina Trenary; Antonio Hernandez; Jessica B Fults; David L Williams; Edward R Sherwood; Julia K Bohannon
Journal:  J Immunol       Date:  2018-04-23       Impact factor: 5.422

Review 6.  The Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma.

Authors:  Margaret A McBride; Allison M Owen; Cody L Stothers; Antonio Hernandez; Liming Luan; Katherine R Burelbach; Tazeen K Patil; Julia K Bohannon; Edward R Sherwood; Naeem K Patil
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.